Back to top
more

Express Scripts Holding Company (ESRX)

(Delayed Data from NSDQ)

$92.33 USD

92.33
NA

0.00 (0.00%)

Updated Dec 20, 2018 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Swarup Gupta headshot

5 Great Healthcare Stocks to Buy for 2019

by Swarup Gupta

Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.

Here's Why You Should Buy Express Scripts (ESRX) Stock Now

by Zacks Equity Research

Strong demand for Express Scripts' (ESRX) solutions like SafeGuardRx, 90-day supply for chronic medications, exclusive Accredo Specialty Pharmacy and advanced opioid solutions buoy optimism.

Is Express Scripts Holding (ESRX) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (ESRX) Outperforming Other Medical Stocks This Year?

Express Scripts Announces 3-Year Agreement With Walmart

by Zacks Equity Research

Express Scripts (ESRX) and Walmart (WMT) collaborate to increase affordable access of the expensive prescription drugs for insured and uninsured patients.

ESRX vs. HQY: Which Stock Is the Better Value Option?

by Zacks Equity Research

ESRX vs. HQY: Which Stock Is the Better Value Option?

Should Value Investors Buy Express Scripts (ESRX) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Express Scripts (ESRX) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Express Scripts (ESRX) Up 4.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Express Scripts (ESRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Express Scripts & Petco Tie Up, Ease Access to Pet Medicines

by Zacks Equity Research

Express Scripts' (ESRX) Inside Rx Pets discount card is likely to make pet medicines affordable.

ESRX or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ESRX vs. HQY: Which Stock Is the Better Value Option?

BioDelivery (BDSI) Q3 Earnings Beat, Sales In Line, Stock Up

by Zacks Equity Research

BioDelivery Sciences (BDSI) reports narrower-than-expected loss in Q3. Sales were almost in line with the consensus mark.

VanEck Launches 2 New ETFs: DURA and GOAT

by Zacks Equity Research

VanEck has rolled out two new ETFs DURA and GOAT which use stock selection and valuation methodologies developed by Morningstar Equity Research.

The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay

ESRX or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ESRX vs. HQY: Which Stock Is the Better Value Option?

Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Mark Vickery headshot

Top Stock Reports for Verizon, Express Scripts & Cigna

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Verizon (VZ), Express Scripts (ESRX), and Cigna (CI).

Stock Market News For Nov 1, 2018

by Zacks Equity Research

Wall Street ended a disastrous October on Wednesday on a winning note buoyed by strong third quarter earnings results from major brand names

Express Scripts (ESRX) Tops Q3 Earnings & Revenue Estimates

by Zacks Equity Research

Express Scripts' (ESRX) Q3 results hurt by year-over-year decline in adjusted network claims, thanks to the loss of certain public sector clients.

Express Scripts (ESRX) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Express Scripts (ESRX) delivered earnings and revenue surprises of 0.41% and 2.28%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Healthcare Q3 Earnings to Watch on Oct 31: ANTM, MOH, ESRX

by Zacks Equity Research

Healthcare stocks should gain from increase in revenues, higher premiums and enrollment partly offset by increase in expenses.

Express Scripts (ESRX) Q3 Earnings Preview: What to Watch Ahead of the Release

by Zacks Equity Research

Express Scripts (ESRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Express Scripts (ESRX) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

Express Scripts (ESRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Express Scripts (ESRX) Q3 Earnings Preview: Here's What to Look Out For

by Zacks Equity Research

Express Scripts (ESRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Express Scripts' (ESRX) Q3 Earnings?

by Zacks Equity Research

Express Scripts (ESRX) likely to see soft PBM revenues in the third quarter of 2018; guidance strong.